New drug SPY002-072 aims to tame multiple inflammatory joint diseases
NCT ID NCT07148414
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 study tests an experimental drug called SPY002-072 in 285 adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. Participants receive either the drug or a placebo, and researchers measure changes in disease activity over time. The goal is to see if the drug can safely reduce joint pain, swelling, and inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SPY002-072 (also called SPY072), an experimental drug
What this could lead to
If successful, this could lead to a new treatment option for people with inflammatory rheumatic diseases like rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.
What could go wrong
This is an early Phase 2 proof-of-concept study, so results are not yet proven. The drug may not work better than placebo, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 102
Tomball, Texas, 77377, United States
-
Site 103
Tomball, Texas, 77375, United States
-
Site 104
Duncansville, Pennsylvania, 16635, United States
-
Site 105
Corpus Christi, Texas, 78404, United States
-
Site 106
Ormond Beach, Florida, 32174, United States
-
Site 107
Whittier, California, 90602, United States
-
Site 108
Tujunga, California, 91042, United States
-
Site 109
Hialeah, Florida, 33016, United States
-
Site 110
Tampa, Florida, 33614, United States
-
Site 111
Covina, California, 91722, United States
-
Site 112
Upland, California, 91786, United States
-
Site 113
Avondale, Arizona, 85392, United States
-
Site 114
Chula Vista, California, 91910, United States
-
Site 115
Aventura, Florida, 33180, United States
-
Site 116
Willowbrook, Illinois, 60527, United States
-
Site 118
Tucson, Arizona, 85748, United States
-
Site 119
Rockville, Maryland, 20850, United States
-
Site 120
Irving, Texas, 75039, United States
-
Site 201
Chisinau, MD-2025, Moldova
-
Site 202
Chisinau, MD-2025, Moldova
-
Site 301
Tbilisi, K'alak'i T'bilisi, 0159, Georgia
-
Site 302
Kutaisi, 4600, Georgia
-
Site 303
Tbilisi, K'alak'i T'bilisi, 0102, Georgia
-
Site 304
Tbilisi, K'alak'i T'bilisi, 0112, Georgia
-
Site 305
Tbilisi, K'alak'i T'bilisi, 0186, Georgia
-
Site 306
Tbilisi, 0186, Georgia
-
Site 307
Tbilisi, K'alak'i T'bilisi, 0172, Georgia
-
Site 308
Batumi, 6010, Georgia
-
Site 401
Krakow, Lesser Poland Voivodeship, 30-363, Poland
-
Site 402
Opole, Opole Voivodeship, 45-819, Poland
-
Site 403
Warsaw, Masovian Voivodeship, 02-677, Poland
-
Site 404
Lodz, Lódzkie, 91-363, Poland
-
Site 405
Warszawa, Pomeranian Voivodeship, 00-874, Poland
-
Site 406
Gdynia, Pomeranian Voivodeship, 81-384, Poland
-
Site 407
Nowa Sól, Lubusz Voivodeship, 67-100, Poland
-
Site 408
Elblag, Warmian-Masurian Voivodeship, 82-300, Poland
-
Site 502
Pleven, Pleven, 5803, Bulgaria
-
Site 503
Lovech, Lovech, 5500, Bulgaria
-
Site 504
Varna, Varna, 9000, Bulgaria
-
Site 505
Plovdiv, Plovdiv, 4003, Bulgaria
-
Site 506
Plovdiv, Plovdiv, 4000, Bulgaria
-
Site 601
Santander, Madrid, 39008, Spain
-
Site 602
A Coruña, A Coruña, 15006, Spain
-
Site 603
Seville, Sevilla, 41010, Spain
-
Site 604
Chiclana de la Frontera, Cadiz, 11139, Spain
-
Site 701
Uherské Hradiště, Zlín, 68601, Czechia
-
Site 702
Moravská Ostrava, Ostrava-město, 702 00, Czechia
-
Site 703
Prague, Praha, Hlavní Mesto, 140 00, Czechia
-
Site 704
Pardubice, Pardubice Region, 530 02, Czechia
-
Site 705
Prague, Praha, Hlavní Mesto, 130 00, Czechia
-
Site 706
Hlučín, Hlučín, 748 01, Czechia
-
Site 801
Vinnytsia, Vinnytsia Oblast, 21028, Ukraine
-
Site 802
Vinnytsia, Vinnytsia Oblast, 21029, Ukraine
-
Site 803
Kyiv, Kyiv Oblast, 2125, Ukraine
-
Site 804
Kyiv, Kyiv Oblast, 04050, Ukraine
-
Site 805
Kyiv, Kyiv Oblast, 4106, Ukraine
-
Site 806
Kyiv, Kyiv Oblast, 03049, Ukraine
-
Site 807
Lviv, Lviv Oblast, 79044, Ukraine
-
Site 808
Ternopil, Ternopil Oblast, 46002, Ukraine
-
Site 809
Chernihiv, Chernihiv Oblast, 14029, Ukraine
-
Site 810
Ternopil, Ternopil Oblast, 46002, Ukraine
-
Site 811
Zhytomyr, Zhytomyr Oblast, 10002, Ukraine
-
Site 812
Vinnytsia, Vinnytska, 21000, Ukraine
-
Site 813
Kyiv, Kyiv Oblast, 02091, Ukraine